ABEO
Price:
$5.77
Market Cap:
$328.86M
Abeona Therapeutics Inc. is a biopharmaceutical company in the clinical development stage, focused on creating innovative gene and cell therapies to address severe and uncommon genetic diseases. Its leading program, EB-101, an autologous gene-corrected cell therapy, is presently in a Phase III clinical trial for treating recessive dystrophic epidermolysis bullosa. The company's pipeline also features several other promising therapies: ABO-102, an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome type A. ABO-201, intended for CLN3 disease. ABO-401, developed to treat cystic fibrosis. ABO-50X, aimed at various genetic eye disorders. Additionally, Abeona is advancing AAV-b...[Read more]
Industry
Biotechnology
IPO Date
1980-09-19
Stock Exchange
NASDAQ
Ticker
ABEO
According to Abeona Therapeutics Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 5.89. This represents a change of -19.53% compared to the average of 7.32 of the last 4 quarters.
The mean historical Current Ratio of Abeona Therapeutics Inc. over the last ten years is 7.09. The current 5.89 Current Ratio has changed 8.21% with respect to the historical average. Over the past ten years (40 quarters), ABEO's Current Ratio was at its highest in in the December 2017 quarter at 25.07. The Current Ratio was at its lowest in in the June 2021 quarter at 1.88.
Average
7.09
Median
5.22
Minimum
2.33
Maximum
25.07
Discovering the peaks and valleys of Abeona Therapeutics Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 199.65%
Maximum Annual Current Ratio = 25.07
Minimum Annual Increase = -82.59%
Minimum Annual Current Ratio = 2.33
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 6.93 | 13.97% |
| 2024 | 6.08 | 46.42% |
| 2023 | 4.15 | -39.16% |
| 2022 | 6.83 | 101.57% |
| 2021 | 3.39 | 45.37% |
| 2020 | 2.33 | -31.90% |
| 2019 | 3.42 | -21.64% |
| 2018 | 4.37 | -82.59% |
| 2017 | 25.07 | 199.65% |
| 2016 | 8.37 | -69.53% |
The current Current Ratio of Abeona Therapeutics Inc. (ABEO) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
5.72
5-year avg
5.47
10-year avg
7.09
Abeona Therapeutics Inc.’s Current Ratio is greater than Tenaya Therapeutics, Inc. (5.75), less than Eledon Pharmaceuticals, Inc. (8.44), greater than Puma Biotechnology, Inc. (2.38), greater than Humacyte, Inc. (3.93), less than Voyager Therapeutics, Inc. (8.42), less than Arcturus Therapeutics Holdings Inc. (6.31), greater than Foghorn Therapeutics Inc. (2.92), less than Sagimet Biosciences Inc. (20.34), less than Assembly Biosciences, Inc. (6.65),
| Company | Current Ratio | Market cap |
|---|---|---|
| 5.75 | $121.72M | |
| 8.44 | $235.00M | |
| 2.38 | $384.80M | |
| 3.93 | $155.30M | |
| 8.42 | $224.77M | |
| 6.31 | $214.03M | |
| 2.92 | $243.66M | |
| 20.34 | $217.65M | |
| 6.65 | $388.42M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Abeona Therapeutics Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Abeona Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Abeona Therapeutics Inc.'s Current Ratio?
How is the Current Ratio calculated for Abeona Therapeutics Inc. (ABEO)?
What is the highest Current Ratio for Abeona Therapeutics Inc. (ABEO)?
What is the 3-year average Current Ratio for Abeona Therapeutics Inc. (ABEO)?
What is the 5-year average Current Ratio for Abeona Therapeutics Inc. (ABEO)?
How does the current Current Ratio for Abeona Therapeutics Inc. (ABEO) compare to its historical average?